Wayne Olson

Executive | $1B+ in Closed Transactions | Capital Strategy | Complex Deal Execution | Emerging Tech


Executive with a 30-year record of capital strategy and complex deal execution. $1B+ in transactions negotiated and completed across all asset classes. Currently exploring CEO, COO, and Chief Strategy Officer roles in emerging tech, life sciences, and neurotech.Cross-disciplinary range across science, finance, and policy. Most effective in white space: novel sectors, capital-constrained ventures, and politically complex deals. Asset-class agnostic deal experience spanning venture capital, private equity, family offices, angel investors, and HNW principals.Distinctive technical depth from neurobiology research at Mayo Clinic in the lab of Dr. Doo-Sup Choi (neurobiology of addiction), including wet lab work in microneurosurgical procedures and optogenetic manipulation of neural circuits. Graduate training in Addiction Studies from Hazelden Graduate School (Summa Cum Laude). Working fluency in neurobiological mechanism and behavioral change.Active R&D as founder and inventor of a proprietary agentic AI cognitive engine applying topological operators to LLM vector environments to reduce model hallucination and increase output reliability. USPTO provisional patent 64/074,183 filed May 2026.

Open to:

  • CEO, COO, Chief Strategy Officer roles

  • Emerging technology, deep tech, AI, and machine learning companies

  • Life sciences, biotech, neurotech, and neuroscience companies

  • Board of Directors and advisory positions

  • Capital-intensive ventures at Angel, VC, Series-A to pre-IPO

  • Venture-backed and PE-backed companies

Core Competencies:

Capital Strategy | Capital Markets | Complex Deal Execution | Mergers & Acquisitions | M&A | Venture Capital | Private Equity | Family Office | Angel Investors | HNW | Real Estate Development | Emerging Technology | Deep Tech | Artificial Intelligence | AI Strategy | AI Architecture | Cognitive Architecture | Machine Learning | Large Language Models | LLM | Neurotechnology | Neuroscience | Life Sciences | Biotech | Patent Strategy | IP Strategy | Board Governance | Public-Private Partnerships | Stakeholder Alignment | Strategic Planning | Executive Leadership